Financials
- Market Capitalization 72.53 M
- Employee 13
- Founded 2012
- CEO N/A
- Website www.atarabio.com
- Headquarter Delaware, United States
- FIGI BBG005Q3MQY4
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4120 | GANX Gain Therapeutics, Inc. - Common Stock | 1.69 USD | -3.98% | -6.63% | -1.17% | -9.14% | 72.09 M USD | ||
| 4133 | PMVP PMV Pharmaceuticals, Inc. - Common Stock | 1.43 USD | +11.72% | +15.32% | +28.83% | +7.52% | 76.26 M USD | ||
| 4151 | IBIO iBio, Inc. - Common Stock | 1.45 USD | 0.00% | -8.81% | -15.20% | -36.96% | 72.03 M USD | ||
| 4156 | XBIT XBiotech Inc. - Common Stock | 2.29 USD | -1.72% | -2.55% | -3.38% | -21.03% | 69.82 M USD |
Frequently asked questions about Atara Biotherapeutics, Inc. - Common Stock
What is the Atara Biotherapeutics, Inc. - Common Stock stock price today?
The current price of Atara Biotherapeutics, Inc. - Common Stock (ATRA) is 8.05. Over the past 24 hours, the stock has changed by -7.15%. Follow the ATRA chart for real-time price dynamics.
What is the stock ticker of Atara Biotherapeutics, Inc. - Common Stock?
Atara Biotherapeutics, Inc. - Common Stock trades under the ticker ATRA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Atara Biotherapeutics, Inc. - Common Stock stock going up?
ATRA has changed by -21.54% over the last week, -23.33% over the last month, and -45.42% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Atara Biotherapeutics, Inc. - Common Stock net income for the last quarter?
Atara Biotherapeutics, Inc. - Common Stock reported net income of -4.14 M for the last quarter. The previous quarter showed -3.41 M, which means net income changed by -21.70%.
How many employees does Atara Biotherapeutics, Inc. - Common Stock have?
As of the latest available data, Atara Biotherapeutics, Inc. - Common Stock has 13 employees. Workforce size can provide additional context about the company's scale and operations.
What is Atara Biotherapeutics, Inc. - Common Stock EBITDA?
Atara Biotherapeutics, Inc. - Common Stock EBITDA is -3.36 M, and its EBITDA margin is -650.39%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Atara Biotherapeutics, Inc. - Common Stock stock?
You can buy Atara Biotherapeutics, Inc. - Common Stock (ATRA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Atara Biotherapeutics, Inc. - Common Stock stock?
Investing in Atara Biotherapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ATRA chart and related analysis on metatrader.com as part of your research.